Gå rett til innhold
Om Legemiddelverket
Kontakt
Nettkart
Presse
Abonnement
English
Jobb i Legemiddelverket
Forside
Forbruker
Helsepersonell
Apotek og grossist
Industri
Meny
About Norwegian Medicines Agency
Clinical trials
Compassionate use
Contact information
Electronic transmission of Adverse Drug Reactions (ADR)
Fees
National implementation of Commission Decision after a Community referral to arbitration
News
Price and reimbursement
Regulatory affairs
Short survey of Norwegian legislation concerning import, wholesaling and retailing of pharmaceuticals.
SPC
Du er her:
Forsiden
/
Welcome to the Norwegian Medicines Agency
/ Electronic transmission of Adverse Drug Reactions (ADR)
Electronic transmission of Adverse Drug Reactions (ADR)
Circular 5/2005 – Electronic transmission of individual case safety reports
Frequently asked questions (FAQ) – Electronic transmission of individual case safety reports